GET THE APP

Journal of Developing Drugs

Journal of Developing Drugs
Open Access

ISSN: 2329-6631

+44 1478 350008

Editorial - (2021)Volume 10, Issue 4

Acknowledgment on Developing Drugs

Hiroyuki Kusuhara*
 
*Correspondence: Hiroyuki Kusuhara, Department of Pharmaceutical Sciences, Osaka University, Japan, Email:

Author info »

I am pleased to introduce the “Journal of Developing Drugs”. The journal is a peer-reviewed, open access that is committed for expeditious publication of articles that draw a compass of the themes related to Development of Drugs. Developing Drugs journal Impact factor is mainly calculated based on the number of articles that undergo a double blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Developing Drugs Open Access Journals are freely accessible to everyone immediately after publication.

Drug development is the process of bringing a new drug molecule into clinical practice. In its broadest definition this encompasses all steps from the basic research process of finding a suitable molecular target to supporting the commercial launch of the drug. Therefore, developing drugs play a crucial role and for giving a platform to the scientists, researchers to establish their studies, their research and views on the drug development. As the journey begins from the labs in the universities which further takes place in the industries. There are several steps that are included in the drug discovery or drug development such as, discovery and development, preclinical research, clinical research, FDA review, FDA post marketing survey etc. It is a huge process which generally takes years for the process of drug development which includes several steps such as the clinical studies with different phases. So, the research starts with the small cellular to the molecular level. Therefore it would be better to understand the developing process.

The main objective of the Journal is to provide an original information round the globe. Here we publish all types of the Researches that are specifically related to Developing Drugs, such that the author can easily publish any form of his or her research based on his feasibility. The forms of researches that can be published in this Journal are mentioned below;

• Review article

• Short Review

• Short communications

• Case studies

• Case series

• Original research articles

This journal that is related to the Pharmaceutical Science adapts to Editorial Manager System for quality in review process. The review process is performed by the editorial board members of Journal of Developing Drugs or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

The journal is engaged and accessible for publishing the articles that are having high quality. Once the manuscript was submitted, the average time between submission and final decision is 21 days and the average time between acceptance and final publication is 14 days. There is a constant support from the Board Members and intellectual indulgence of the readers and contributors i.e., authors and reviewers.

Author Info

Hiroyuki Kusuhara*
 
Department of Pharmaceutical Sciences, Osaka University, Yamadaoka, Osaka, Japan
 

Received: 14-Jul-2021 Accepted: 27-Jul-2021 Published: 03-Aug-2021 , DOI: 10.35248/2329-6631.21.10.e156

Copyright: This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Top